You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKesson
Moodys
Express Scripts
Mallinckrodt

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Cefotaxime sodium - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cefotaxime sodium and what is the scope of freedom to operate?

Cefotaxime sodium is the generic ingredient in seven branded drugs marketed by Fresenius Kabi Usa, Hikma, Wockhardt, B Braun, Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira Inc, Lupin, Sanofi Aventis Us, and Us Pharm Holdings, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for cefotaxime sodium. Two suppliers are listed for this compound.

Recent Clinical Trials for cefotaxime sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fayoum University HospitalPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all cefotaxime sodium clinical trials

Pharmacology for cefotaxime sodium
Medical Subject Heading (MeSH) Categories for cefotaxime sodium

US Patents and Regulatory Information for cefotaxime sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharm Holdings CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Us Pharm Holdings CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065516-001 Nov 6, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Us Pharm Holdings CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-004 Dec 29, 1983 DISCN Yes No   Start Trial   Start Trial   Start Trial
Hospira Inc CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 203132-002 Feb 19, 2016 DISCN No No   Start Trial   Start Trial   Start Trial
Wockhardt CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065197-003 Jun 20, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Express Scripts
Colorcon
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.